When Hysteroscopic Surgery May Help in Adenomyosis

Medically reviewed on 13 November 2026 - Dr. Senai Aksoy
A woman noting down questions about her treatment in a quiet library

Key Takeaways

Hysteroscopic surgery may be discussed for selected adenomyosis lesions that can be reached from inside the uterus. It does not remove all deep or widespread disease, and a live-birth benefit has not been established. GnRH agonists (medicines that temporarily suppress hormones) before frozen embryo transfer are weighed case by case. They are not a routine treatment, and their effect on live birth is not established.

Key evidence: Review: hysteroscopy and adenomyosis Small surgical series: selected patients Meta-analysis: GnRH pretreatment before FET

Hysteroscopy: When Is It Necessary? — Dr. Senai Aksoy

Hysteroscopy: When Is It Necessary? — Dr. Senai Aksoy

This video is in French; English and Arabic subtitles are available in the YouTube player.

When hysteroscopy may help

Adenomyosis means tissue like the uterine lining is growing within the muscle of the uterus. It may cause heavy bleeding, pain and fertility problems, but symptoms and the extent of disease vary widely (Pados and colleagues’ review).

Hysteroscopy uses a thin camera passed through the cervix to inspect the uterine cavity. In operative hysteroscopy, the surgeon may remove or drain some superficial or cystic lesions that can be reached from the cavity. Abdominal or laparoscopic surgery for deeper adenomyosis is a separate operation (review of hysteroscopic treatment).

For the wider treatment picture, see adenomyosis and IVF.

What makes a lesion suitable?

The key question is whether a specific lesion can be reached and treated safely without removing too much healthy muscle. A focal lesion bulging towards the cavity, troublesome bleeding and the response to earlier medical treatment may all shape the discussion. Wanting to keep the uterus matters, but whether hysteroscopy fits depends on the lesion and on these findings.

Ultrasound shows where the disease is and how deep it goes. Magnetic resonance imaging (MRI) may add detail when the ultrasound is unclear or the anatomy needs further mapping (review of diagnosis and treatment).

An adenomyosis lesion may have no clear boundary with healthy muscle. That limits how much tissue can safely be removed. Treating tissue that can be reached from the cavity does not remove deep or widespread adenomyosis (hysteroscopic treatment review).

What do we know about fertility benefit?

So far, the evidence is limited. Relieving bleeding or treating a lesion inside the cavity is a surgical goal. Reaching that goal does not show that the operation improves implantation or live birth (a baby born alive).

A 2025 report by Campo and colleagues described pregnancies after hysteroscopic cytoreductive surgery in carefully selected women with repeated failed transfers. Because the series included only 15 women and had no comparison group, it cannot show how much surgery changed the outcome.

Evidence box: who was in the Campo series?

This was a single-centre video report. All 15 women were under 37 and had failed to conceive after medical treatment and at least two transfers of high-quality blastocysts. Blastocysts are embryos at an advanced stage of development. Every woman also received hormonal suppression with dienogest or a GnRH agonist (triptorelin), so the pregnancies cannot be credited to surgery alone. At the time of reporting, four had delivered, seven had ongoing pregnancies and one had an early miscarriage (Campo and colleagues, 2025).

Results from abdominal or laparoscopic adenomyosis surgery do not carry over to hysteroscopic treatment. The techniques, patient groups and risks differ (review of medical and surgical approaches).

GnRH agonists before frozen embryo transfer

GnRH agonists are medicines that temporarily suppress hormone activity. They may be discussed as preparation before a frozen embryo transfer (FET). Whether to use them is a separate decision from choosing the ovarian stimulation protocol used to collect eggs.

A 2025 systematic review and meta-analysis pooled the results of earlier studies. It did not demonstrate better live-birth outcomes when GnRH agonist pretreatment was added to hormone replacement preparation for FET. Most included studies were retrospective, meaning they looked back at existing records rather than randomly assigning treatment, and their results varied. Whether a selected subgroup benefits remains uncertain. A drop in symptoms or uterine size during pretreatment does not show that the chance of live birth has risen.

Risks and recovery

Any hysteroscopy carries risks of bleeding, infection and uterine perforation (a hole in the uterine wall) (RCOG patient information). For hysteroscopy in general, see hysteroscopy and female infertility.

Adenomyosis surgery adds its own concerns. Intrauterine adhesions (scar tissue inside the uterus) may form. In one small series, second-look hysteroscopy found mild adhesions in 3 of 13 women (Campo and colleagues). Symptoms may also persist or come back, sometimes needing a second procedure (procedure-specific review). How large these risks are depends on the lesion and the procedure. Surgery that keeps the uterus still carries them. Keeping the uterus and improving the chance of live birth are also different outcomes.

Recovery and follow-up depend on how much tissue is treated. The surgical team should explain when you can resume activities and how healing will be checked before a transfer. How long to wait before embryo transfer is answered in the questions below.

Frequently Asked Questions for Dr. Aksoy

Does hysteroscopic adenomyosis surgery improve the chance of pregnancy or IVF success?

Adenomyosis means tissue like the lining of the uterus lies within the uterine muscle. That is why hysteroscopy cannot reach every adenomyotic focus. However, hysteroscopic surgery may be considered for some limited lesions close to the cavity.

Does the operation raise the chance of pregnancy? Some small studies have reported favourable pregnancy results after surgery, but today we cannot say for certain that hysteroscopic adenomyosis surgery improves the chance of live birth with IVF. I do not recommend this operation routinely, particularly in diffuse adenomyosis. Surgery on the uterine wall can also carry risks such as adhesions, damage to uterine tissue and complications in a later pregnancy.

My approach is to weigh age, ovarian reserve, where the disease sits, symptoms and previous IVF results together. I decide on surgery according to whether it will genuinely help, not simply because ultrasound shows adenomyosis.

Is a GnRH agonist necessary before frozen embryo transfer in adenomyosis?

I do not give every patient with adenomyosis a three-month course of a GnRH agonist before frozen embryo transfer. These medicines temporarily suppress ovarian hormones and may ease pain, bleeding and uterine enlargement linked to adenomyosis. I may consider them especially when disease is diffuse, the uterus is clearly enlarged or symptoms are severe, or when good-quality embryos have already failed to implant or pregnancies have been lost.

There is one important point, though: it has not been shown conclusively that GnRH agonists raise the chance of live birth after frozen embryo transfer. If disease is mild and the cavity is suitable, especially if a first transfer is planned, going straight to transfer is also a reasonable option. I do not automatically give everyone three months of suppression. I weigh the possible benefit, the side effects and the delay the treatment would create.

How long should I wait after hysteroscopy before embryo transfer?

The interval depends on what was done. After a diagnostic look inside the uterus with no problem found, a long wait is usually unnecessary. After removal of a small polyp, embryo transfer can be planned in the next menstrual cycle for most patients.

If a large fibroid was removed, extensive adhesions were divided, or the lining needed a more involved procedure, healing may take longer. Some patients may also need a second-look hysteroscopy. Especially when adenomyosis surgery has involved the muscle layer, the wait has to be set according to how deep the operation went and how the wall is healing. What matters to me is not waiting a fixed number of months, but being sure that the cavity is healthy and ready for pregnancy at the time of transfer.

Dr. Aksoy’s approach

When suppression before FET is being considered and age is advancing or ovarian reserve is limited, we also need to weigh the cost of waiting for months.

Even in selected severe cases, I do not regard the live-birth benefit of GnRH agonists before FET as established.

Dr. Senai Aksoy — clinical input provided on 27 September 2026.

Sources

Next step

A question about your own case?

An article can set out the general picture, but not what applies to your own history. If you would like your situation looked at, you can send your questions and any previous reports to the medical team.

For privacy, please send only information needed for an initial reply. Ask the team which secure channel to use for medical reports or identity documents.

Request a medical review

Add as a Preferred Source on Google

You can add draksoyivf.com as one of your preferred health information sources on Google.

Add on Google
Dr. Senai Aksoy

Dr. Senai Aksoy studied and trained in France before returning to Turkey, where he was a member of the ICSI team at Sevgi Hospital, Ankara — the country's first ICSI centre (1994-95) — and a co-author on the first Turkish ICSI publications produced in collaboration with the Brussels Van Steirteghem group (Human Reproduction, 1996; PMID 8671323). He helped build the IVF programme at the American Hospital Istanbul and has been running his own fertility practice since 1998.

Verified profiles: PubMed ORCID LinkedIn

The content has been created by Dr. Senai Aksoy and medically approved.

Before getting in touch

Please note that certain services, such as sperm donation, egg donation, surrogacy and gender selection (without medical necessity), are not permitted under Turkish law.

We would like to inform you that our clinic strictly adheres to these regulations and does not offer any of these services.

Continue